Lacosamide 70710-1886
Product NDC
70710-1886- Manufacturer
- Zydus Pharmaceuticals Usa Inc.
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- November 10, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA209465
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 10 mg/mL |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(1)
10 VIAL in 1 CARTON (70710-1886-6) / 20 mL in 1 VIAL (70710-1886-1)